These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells. Crick DC; Waechter CJ; Andres DA SAAS Bull Biochem Biotechnol; 1996; 9():37-42. PubMed ID: 8652130 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Halasy-Nagy JM; Rodan GA; Reszka AA Bone; 2001 Dec; 29(6):553-9. PubMed ID: 11728926 [TBL] [Abstract][Full Text] [Related]
24. Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells. Ownby SE; Hohl RJ Lipids; 2002 Feb; 37(2):185-92. PubMed ID: 11908910 [TBL] [Abstract][Full Text] [Related]
25. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343 [TBL] [Abstract][Full Text] [Related]
26. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Fisher JE; Rodan GA; Reszka AA Endocrinology; 2000 Dec; 141(12):4793-6. PubMed ID: 11108295 [TBL] [Abstract][Full Text] [Related]
27. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. Samanna V; Ma T; Mak TW; Rogers M; Chellaiah MA J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356 [TBL] [Abstract][Full Text] [Related]
28. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593 [TBL] [Abstract][Full Text] [Related]
29. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Miquel K; Pradines A; Favre G Biochem Biophys Res Commun; 1996 Aug; 225(3):869-76. PubMed ID: 8780704 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791 [TBL] [Abstract][Full Text] [Related]
31. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Van Beek ER; Löwik CW; Papapoulos SE Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566 [TBL] [Abstract][Full Text] [Related]
32. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051 [TBL] [Abstract][Full Text] [Related]
34. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. Johnson MD; Woodard A; Okediji EJ; Toms SA; Allen GS J Neurooncol; 2002 Jan; 56(2):133-42. PubMed ID: 11995814 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765 [TBL] [Abstract][Full Text] [Related]
36. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100 [TBL] [Abstract][Full Text] [Related]
37. Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. Marcuzzi A; Zanin V; Piscianz E; Tricarico PM; Vuch J; Girardelli M; Monasta L; Bianco AM; Crovella S Int J Dev Neurosci; 2012 Oct; 30(6):451-6. PubMed ID: 22759742 [TBL] [Abstract][Full Text] [Related]
38. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor. van Beek E; Löwik C; Karperien M; Papapoulos S Bone; 2006 Feb; 38(2):167-71. PubMed ID: 16165408 [TBL] [Abstract][Full Text] [Related]
39. Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity. Suri S; Mönkkönen J; Taskinen M; Pesonen J; Blank MA; Phipps RJ; Rogers MJ Bone; 2001 Oct; 29(4):336-43. PubMed ID: 11595616 [TBL] [Abstract][Full Text] [Related]
40. Alendronate disturbs vesicular trafficking in osteoclasts. Alakangas A; Selander K; Mulari M; Halleen J; Lehenkari P; Mönkkönen J; Salo J; Väänänen K Calcif Tissue Int; 2002 Jan; 70(1):40-7. PubMed ID: 11907706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]